Eva Fernlund1,2, Antheia Kissopoulou3, Henrik Green4,5, Jan-Erik Karlsson3, Rada Ellegård6, Hanna Klang Årstrand6, Jon Jonasson6, Cecilia Gunnarsson6,7. 1. Crown Princess Victoria Children's Hospital, and Department of Biomedical and Clinical Sciences, Department of Pediatrics, Linköping University, 581 83 Linköping, Sweden. 2. Department of Clinical Sciences Lund, Pediatric Heart Center, Skåne University Hospital, Lund University, 221 00 Lund, Sweden. 3. Department of Internal Medicine, County Council of Jönköping, Department of Health, Medicine and Caring Sciences, Linköping University, 581 83 Linköping, Sweden. 4. Division of Drug Research, Department of Biomedical and Clinical Sciences, Linköping University, 581 83 Linköping, Sweden. 5. Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, 111 64 Stockholm, Sweden. 6. Department of Clinical Genetics, and Department of Biomedical and Clinical Sciences, Linköping University, 581 83 Linköping, Sweden. 7. Centre for Rare Diseases in South East Region of Sweden, Linköping University, 581 83 Linköping, Sweden.
Abstract
INTRODUCTION: Sudden cardiac death (SCD) and early onset cardiomyopathy (CM) in the young will always lead to suspicion of an underlying genetic disorder. Incited by the rapid advances in genetic testing for disease we have revisited families, which previously tested "gene-negative" for familial predominantly pediatric CM, in hopes of finding a causative gene variant. METHODS: 10 different families with non-syndromic pediatric CM or hypertrophic cardiomyopathy (HCM) with severe disease progression and/or heredity for HCM/CM related SCD with "gene-negative" results were included. The index patient underwent genetic testing with a recently updated gene panel for CM and SCD. In case of failure to detect a pathogenic variant in a relevant gene, the index patient and both parents underwent clinical (i.e., partial) exome sequencing (trio-exome) in order to catch pathogenic variants linked to the disease in genes that were not included in the CM panel. RESULTS: The mean age at clinical presentation of the 10 index cases was 12.5 years (boys 13.4 years, n = 8; girls 9 years, n = 2) and the family history burden was 33 HCM/CM cases including 9 HCM-related SCD and one heart transplantation. In 5 (50%) families we identified a genetic variant classified as pathogenic or likely pathogenic, in accordance with the American College of Medical Genetics and Genomics (ACMG) criteria, in MYH7 (n = 2), RBM20, ALPK3, and PGM1, respectively, and genetic variants of unknown significance (VUS) segregating with the disease in an additional 3 (30%) families, in MYBPC3, ABCC9, and FLNC, respectively. CONCLUSION: Our results show the importance of renewed thorough clinical assessment and the necessity to challenge previous genetic test results with more comprehensive updated gene panels or exome sequencing if the initial test failed to identify a causative gene for early onset CM or SCD in children. In pediatric cardiomyopathy cases when the gene panel still fails to detect a causative variant, a trio exome sequencing strategy might resolve some unexplained cases, especially if a multisystemic condition is clinically missed.
INTRODUCTION:Sudden cardiac death (SCD) and early onset cardiomyopathy (CM) in the young will always lead to suspicion of an underlying genetic disorder. Incited by the rapid advances in genetic testing for disease we have revisited families, which previously tested "gene-negative" for familial predominantly pediatric CM, in hopes of finding a causative gene variant. METHODS: 10 different families with non-syndromic pediatric CM or hypertrophic cardiomyopathy (HCM) with severe disease progression and/or heredity for HCM/CM related SCD with "gene-negative" results were included. The index patient underwent genetic testing with a recently updated gene panel for CM and SCD. In case of failure to detect a pathogenic variant in a relevant gene, the index patient and both parents underwent clinical (i.e., partial) exome sequencing (trio-exome) in order to catch pathogenic variants linked to the disease in genes that were not included in the CM panel. RESULTS: The mean age at clinical presentation of the 10 index cases was 12.5 years (boys 13.4 years, n = 8; girls 9 years, n = 2) and the family history burden was 33 HCM/CM cases including 9 HCM-related SCD and one heart transplantation. In 5 (50%) families we identified a genetic variant classified as pathogenic or likely pathogenic, in accordance with the American College of Medical Genetics and Genomics (ACMG) criteria, in MYH7 (n = 2), RBM20, ALPK3, and PGM1, respectively, and genetic variants of unknown significance (VUS) segregating with the disease in an additional 3 (30%) families, in MYBPC3, ABCC9, and FLNC, respectively. CONCLUSION: Our results show the importance of renewed thorough clinical assessment and the necessity to challenge previous genetic test results with more comprehensive updated gene panels or exome sequencing if the initial test failed to identify a causative gene for early onset CM or SCD in children. In pediatric cardiomyopathy cases when the gene panel still fails to detect a causative variant, a trio exome sequencing strategy might resolve some unexplained cases, especially if a multisystemic condition is clinically missed.
Authors: Carolyn Y Ho; Siddique A Abbasi; Tomas G Neilan; Ravi V Shah; Yucheng Chen; Bobak Heydari; Allison L Cirino; Neal K Lakdawala; E John Orav; Arantxa González; Begoña López; Javier Díez; Michael Jerosch-Herold; Raymond Y Kwong Journal: Circ Cardiovasc Imaging Date: 2013-04-02 Impact factor: 7.792
Authors: Khalfan Al Senaidi; Niranjan Joshi; Maryam Al-Nabhani; Ghalia Al-Kasbi; Abdullah Al Farqani; Khalid Al-Thihli; Almundher Al-Maawali Journal: Am J Med Genet A Date: 2019-05-10 Impact factor: 2.802
Authors: Steven D Colan; Steven E Lipshultz; April M Lowe; Lynn A Sleeper; Jane Messere; Gerald F Cox; Paul R Lurie; E John Orav; Jeffrey A Towbin Journal: Circulation Date: 2007-01-29 Impact factor: 29.690
Authors: Sunnie Yan-Wai Wong; Lesa J Beamer; Therese Gadomski; Tomas Honzik; Miski Mohamed; Saskia B Wortmann; Katja S Brocke Holmefjord; Marit Mork; Francis Bowling; Jolanta Sykut-Cegielska; Dieter Koch; Amanda Ackermann; Charles A Stanley; Daisy Rymen; Avraham Zeharia; Moeen Al-Sayed; Thomas Marquardt; Jaak Jaeken; Dirk Lefeber; Donald F Conrad; Tamas Kozicz; Eva Morava Journal: J Pediatr Date: 2016-05-17 Impact factor: 4.406
Authors: Jamie A Decker; Joseph W Rossano; E O'Brian Smith; Bryan Cannon; Sarah K Clunie; Corey Gates; John L Jefferies; Jeffrey J Kim; Jack F Price; William J Dreyer; Jeffrey A Towbin; Susan W Denfield Journal: J Am Coll Cardiol Date: 2009-07-14 Impact factor: 24.094
Authors: Rowida Almomani; Judith M A Verhagen; Johanna C Herkert; Erwin Brosens; Karin Y van Spaendonck-Zwarts; Angeliki Asimaki; Paul A van der Zwaag; Ingrid M E Frohn-Mulder; Aida M Bertoli-Avella; Ludolf G Boven; Marjon A van Slegtenhorst; Jasper J van der Smagt; Wilfred F J van IJcken; Bert Timmer; Margriet van Stuijvenberg; Rob M Verdijk; Jeffrey E Saffitz; Frederik A du Plessis; Michelle Michels; Robert M W Hofstra; Richard J Sinke; J Peter van Tintelen; Marja W Wessels; Jan D H Jongbloed; Ingrid M B H van de Laar Journal: J Am Coll Cardiol Date: 2016-02-09 Impact factor: 24.094
Authors: Robert Jablonowski; Eva Fernlund; Anthony H Aletras; Henrik Engblom; Einar Heiberg; Petru Liuba; Håkan Arheden; Marcus Carlsson Journal: Pediatr Cardiol Date: 2015-06-12 Impact factor: 1.655
Authors: Roddy Walsh; Kate L Thomson; James S Ware; Birgit H Funke; Jessica Woodley; Karen J McGuire; Francesco Mazzarotto; Edward Blair; Anneke Seller; Jenny C Taylor; Eric V Minikel; Daniel G MacArthur; Martin Farrall; Stuart A Cook; Hugh Watkins Journal: Genet Med Date: 2016-08-17 Impact factor: 8.822
Authors: Antonio Rueda Martin; Eleanor Williams; Rebecca E Foulger; Sarah Leigh; Louise C Daugherty; Olivia Niblock; Ivone U S Leong; Katherine R Smith; Oleg Gerasimenko; Eik Haraldsdottir; Ellen Thomas; Richard H Scott; Emma Baple; Arianna Tucci; Helen Brittain; Anna de Burca; Kristina Ibañez; Dalia Kasperaviciute; Damian Smedley; Mark Caulfield; Augusto Rendon; Ellen M McDonagh Journal: Nat Genet Date: 2019-11 Impact factor: 38.330